During the past 4 months, medicine throughout the world has been challenged on how COVID-19 impacts our body and how best to treat it.
This observational study adds more information. Further study is needed to determine whether or not this is medically relevant.
https://www.jaad.org/article/S0190-9622(2)30948-8/pdf
You Might Also Enjoy...
These are the first two CME articles on hair transplantation to ever be published in the leading peer reviewed journal in our field. I am proud to be one of its authors.
During the American Academy of Dermatology (AAD) virtual meeting experience, I was happy to participate in this very informative session on innovative therapeutic tools to slow hair loss and increase hair growth.
For some highly motivated patients, a combination of two therapies can be effective in helping hair loss.
The New England Journal of Medicine published an interesting article on vaccine effectiveness and the need for boosters.
The attached article from the FDA outlines the medical risks associated with JAK(Janus kinase) inhibitors for the treatment of alopecia totalis and universalis.
This report gives patients a new and safe therapeutic option to treat chronic inflammatory scalp disorders like folliculitis decalvans.
